{"title":"甲状腺癌放射碘治疗后的泪腺和唾液腺功能障碍","authors":"Ricardo Villela, Ricardo Correa","doi":"10.1089/ct.2023;35.384-386","DOIUrl":null,"url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Thyroid CancerLacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid CancerRicardo Villela and Ricardo CorreaRicardo Villela Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this author and Ricardo Correa Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.384-386AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Ricardo Villela and Ricardo Correa.Lacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid Cancer.Clinical Thyroidology®.Sep 2023.384-386.http://doi.org/10.1089/ct.2023;35.384-386Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid Cancer\",\"authors\":\"Ricardo Villela, Ricardo Correa\",\"doi\":\"10.1089/ct.2023;35.384-386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clinical Thyroidology®Vol. 35, No. 9 Thyroid CancerLacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid CancerRicardo Villela and Ricardo CorreaRicardo Villela Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this author and Ricardo Correa Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.384-386AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Ricardo Villela and Ricardo Correa.Lacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid Cancer.Clinical Thyroidology®.Sep 2023.384-386.http://doi.org/10.1089/ct.2023;35.384-386Published in Volume: 35 Issue 9: September 13, 2023PDF download\",\"PeriodicalId\":72629,\"journal\":{\"name\":\"Clinical thyroidology\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical thyroidology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ct.2023;35.384-386\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2023;35.384-386","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Lacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid Cancer
Clinical Thyroidology®Vol. 35, No. 9 Thyroid CancerLacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid CancerRicardo Villela and Ricardo CorreaRicardo Villela Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this author and Ricardo Correa Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Arizona College of Medicine—Phoenix, Phoenix, Arizona, U.S.A.Search for more papers by this authorPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.384-386AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Ricardo Villela and Ricardo Correa.Lacrimal and Salivary Gland Dysfunction Following Radioiodine Therapy for Thyroid Cancer.Clinical Thyroidology®.Sep 2023.384-386.http://doi.org/10.1089/ct.2023;35.384-386Published in Volume: 35 Issue 9: September 13, 2023PDF download
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
